Tuesday | Archives General Psychiatry
The Value of Specifying Brand-name Antiepileptic Drugs [Controversies in Neurology]
Yu-tze Ng, MD, FRACP Arch Neurol. 2009;66 :1415-1416. The patent lives of most of the newer-generation antiepileptic drugs have either expired or come close to expiration.
Despite potentially deadly seizures, Dandridge woman losing TennCare
"I'm 38 years old and I don't want to die." According to TennCare, Tonya Duford is days away from having no health insurance and no ability to pay for her anti-seizure drug called Keppra, with an out-of-pocket cost of one-thousand dollars a month.
"Pfizer Math" Showed Lyrica Superiority Even Though Studies Never Said That, Rep Claims
Pfizer used "Pfizer Math" to persuade doctors that studies showed Lyrica was superior to two anti-seizure drugs, Neurontin and Keppra , when no comparable studies had been done - and Lyrica was not approved to treat seizures - according to two former pharmaceutical sales reps.
Functional evaluation of polymorphisms in the human ABCB1 gene and...
The aim of this study is to investigate whether ABCB1 haplotype combinations would affect P-glycoprotein function and impact the clinical responses of antiepileptic drugs .
UCB progress: new product launches and financials on track
Royalty income increased by 35% to EUR 114 million supported by the launch of Toviaz .
MEDICATION ERRORS SIMILAR NAMES Compounding the error A hospitalized patient with a seizure disorder was receiving 750 mg of I.V. levetiracetam, an antiepileptic drug, every 12 hours.
UCB Receives CHMP Positive Opinion On Keppra(R) For Infants And Young ...
UCB announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending that the European Commission grant marketing authorisation for Keppra as adjunctive treatment of partial-onset seizures in infants and young children aged one month to under four years.
Charlotte Gentry didn't realize that her epilepsy prescriptions had been changed from name brand to generic until after she had seizures that sent her to the emergency room.
Spotswood teen with epilepsy graduates - along with loyal companion dog
Spotswood High School graduate Kate Miller - who experiences epileptic seizures - got through her junior and senior years of high school thanks largely to Greta, a golden retriever who remained at her side throughout the school day.
Norfolk patients face drug shortages
Patients are facing delays in getting medicines and pharmacists are having difficulties because of shortages of a wide range of drugs.
Ed Blonz: Local fruits just as good as exotic
DEAR DR. BLONZ: I recently purchased a product containing the juice of four berries: goji, noni, acai and mangosteen, all supposedly rich in antioxidant power.
Levetiracetam promising for refractory status epilepticus
Intravenous levetiracetam appears to be a promising alternative therapy for refractory status epilepticus, German researchers report in the June issue of the Journal of Neurology, Neurosurgery and Psychiatry.
Consumer Reports to generic skeptics: show us the evidence
To those who continue to sing the tired old tune that generic drugs are not as effective as brand name drugs, Consumer Reports wants to see the evidence.
I noticed when I posted that last item that I've been quiet on the blog front lately and I know at a least a few of my dozen or so loyal readers are wondering why.
FDA Issues an Update about Suicidal Behavior and Ideation and Antiepileptic Drugs
ROCKVILLE, Md., May 5, 2009--The FDA posted the following on its website about product labeling for antiepileptic drugs: Suicidal Behavior and Ideation and Antiepileptic Drugs Update 5/5/2009: AED class label changes Manufacturers of antiepileptic drugs or anticonvulsant drugs will update product labeling to include a warning about an increased ...
FDA also required development of a medication guide, to be issued to patients each time the product is dispensed.
Ucb S.Aa : Ucb focuses on new product launches
"In the first three months of 2009, UCB has made further progress in focusing its resources and organisation on its core priorities in severe diseases of the central nervous system and immunology.
UCB's CEO statement at AGM: UCB executing on its strategy
Today, UCB held its Annual General Meeting . During the course of this meeting Roch Doliveux, Chief Executive Officer UCB, gave the shareholders of UCB an overview of the financial year 2008 and the interim report for the first three months of 2009 including an update on the most recent development of UCB.
Also on Topix